Olympus Targets A Bigger Medical Future

A medical company that has some other businesses – that is the shorthand description that Olympus Corp. of the Americas president and CEO Nacho Abia ascribes to a group that has emerged from difficult times with a new strategy, new structure and new determination. Targeted deals and M&A remain as important as ever to the group as it embarks, somewhat reinvented, on a new five-year plan.

IV1608_Target-Arrow_1200x675

The past is the past, and we have to learn from it, says Olympus Corp. of the Americas (Center Valley, PA) president and CEO Nacho Abia. He is talking to In Vivo during the ninth annual Global Medtech Compliance Conference (GMTCC), in Dublin, Ireland. His attendance on a panel discussing broad themes revolving around the importance of compliance speaks volumes for a company that has suffered all the negative attention that a financial scandal brings with it.

Abia is in fact keen to shine the spotlight onto a group where he has had responsibilities at the senior...

More from Growth

More from In Vivo